Stay updated with breaking news from Red platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neue Studie beurteilt den Einsatz von Masimo PVi zur Überwachung des Volumenstatus bei spontan atmenden Hämodialysepatienten finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Studie zur Nützlichkeit von Masimo O3 bei der Überwachung von IPS-Patienten mit septischem Schock und der Vorhersage der Sterblichkeit finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Rubius Therapeutics posts $42.3M loss in Q1 RUBIUS THERAPEUTICS reported a $42.3 million loss in the first quarter of 2021. CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported a $42.3 million loss in the first quarter of 2021, or 51 cents per diluted share, the company said Monday. The clinical-stage biopharmaceutical company posted a $48.5 million loss in the first quarter one year prior, or 60 cents per diluted share. The company owns and operates a manufacturing facility in North Smithfield. In the first quarter of 2021, the company incurred $27.7 million in research and development costs, a decline from $36.2 million one year prior, and $13.2 million in general and administrative costs, an increase from $12.7 million one year prior. ....